{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:49:56Z","timestamp":1793321396479,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.berh.2024.101979","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:58:32Z","timestamp":1721782712000},"page":"101979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of JIA associated uveitis"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-3254","authenticated-orcid":false,"given":"Ilaria","family":"Maccora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Guly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-2401","authenticated-orcid":false,"given":"Athimalaipet V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2024.101979_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.berh.2024.101979_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ophtha.2009.05.002","article-title":"Epidemiology and course of disease in childhood uveitis","volume":"116","author":"Smith","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2024.101979_bib3","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/BOR.0000000000000723","article-title":"Update on noninfectious uveitis in children and its treatment","volume":"32","author":"Maccora","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.40885","article-title":"American College of rheumatology\/arthritis foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/09273948.2020.1834586","article-title":"Widefield fundus fluorescein angiography features of uveitis associated with juvenile idiopathic arthritis","volume":"30","author":"Tripathy","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/1744666X.2019.1593139","article-title":"Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice","volume":"15","author":"Haasnoot","year":"2019","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101979_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ajo.2014.11.007","article-title":"Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis","volume":"159","author":"Haasnoot","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.40484","article-title":"Identification of an amino acid motif in HLA-DR\u03b21 that distinguishes uveitis in patients with juvenile idiopathic arthritis","volume":"70","author":"Haasnoot","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jbspin.2019.06.001","article-title":"The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases","volume":"86","author":"Hayworth","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2024.101979_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/rheumatology\/key406","article-title":"Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study","volume":"58","author":"Heiligenhaus","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101979_bib12","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1167\/iovs.15-17066","article-title":"Elevated S100A8\/A9 and S100A12 serum levels reflect intraocular inflammation in juvenile idiopathic arthritis-associated uveitis: results from a pilot study","volume":"56","author":"Walscheid","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2024.101979_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.40544","article-title":"Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the inception cohort of newly diagnosed patients with juvenile idiopathic arthritis study","volume":"70","author":"Tappeiner","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1080\/09273948.2020.1758731","article-title":"S100 proteins, cytokines, and chemokines as tear biomarkers in children with juvenile idiopathic arthritis-associated uveitis","volume":"29","author":"Angeles-Han","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-018-0156-5","article-title":"Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study","volume":"8","author":"Angeles-Han","year":"2018","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.berh.2024.101979_bib16","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.12-10865","article-title":"Intraocular biomarker identification in uveitis associated with juvenile idiopathic arthritis","volume":"54","author":"Kalinina","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2024.101979_bib17","first-page":"390","article-title":"Canadian rheumatology association recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"50","author":"Berard","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib18","first-page":"1107","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101979_bib19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","article-title":"Uveitis associated with juvenile idiopathic arthritis","volume":"11","author":"Sen","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2024.101979_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/09273948.2013.855798","article-title":"Juvenile idiopathic arthritis-associated uveitis at an Italian tertiary referral center: clinical features and complications","volume":"23","author":"Paroli","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.autrev.2017.10.007","article-title":"HLA-DRB1 alleles and juvenile idiopathic arthritis: diagnostic clues emerging from a meta-analysis","volume":"16","author":"Silvestri","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101979_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jbspin.2016.04.014","article-title":"Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis","volume":"84","author":"Pers","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.berh.2024.101979_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115236","article-title":"JAK-STAT signaling pathway in non-infectious uveitis","volume":"204","author":"Su","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.berh.2024.101979_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2019.03.004","article-title":"Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Wildsch\u00fctz","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2024.101979_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2024.101979_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/1744666X.2023.2207823","article-title":"Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis","volume":"19","author":"Maccora","year":"2023","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101979_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.berh.2024.101979_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640473","article-title":"Pathogenesis of non-infectious uveitis elucidated by recent genetic findings","volume":"12","author":"Takeuchi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2024.101979_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjophthalmol-2018-313789","article-title":"Areas of agreement in the management of childhood non-infectious chronic anterior uveitis in the UK","volume":"104","author":"Solebo","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003010","article-title":"Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-na\u00efve juvenile idiopathic arthritis","author":"van Straalen","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101979_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/acr.24483","article-title":"Temporal relationship between juvenile idiopathic arthritis disease activity and uveitis disease activity","volume":"74","author":"Liebling","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101979_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajo.2008.06.004","article-title":"Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/art.41530","article-title":"Imaging-based uveitis surveillance in juvenile idiopathic arthritis: feasibility, acceptability, and diagnostic performance","volume":"73","author":"Akbarali","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12969-024-00961-9","article-title":"Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study","volume":"22","author":"Ede","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2024.101979_bib37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/bjophthalmol-2021-320448","article-title":"Quantitative and qualitative assessment of anterior segment optical coherence tomography capture of disease state in childhood anterior uveitis","volume":"107","author":"Etherton","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12112703","article-title":"Automated quantitative analysis of anterior segment inflammation using swept-source anterior segment optical coherence tomography: a pilot study","author":"Keino","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.berh.2024.101979_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13203179","article-title":"Laser flare photometry to monitor childhood chronic uveitis: a preliminary report of a monocentric Italian experience","author":"Maccora","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.berh.2024.101979_bib40","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2015.02.032","article-title":"Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography","volume":"122","author":"Sharma","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2024.101979_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","article-title":"Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation","volume":"30","author":"Tugal-Tutkun","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/1744666X.2023.2198210","article-title":"Challenges and management of childhood noninfectious chronic uveitis","volume":"19","author":"Maccora","year":"2023","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101979_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ceo.13470","article-title":"Optical coherence tomography and optical coherence tomography angiography in uveitis: a review","volume":"47","author":"Invernizzi","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib44","article-title":"New and updated recommendations for the treatment of juvenile idiopathic arthritis associated uveitis and idiopathic chronic anterior uveitis","author":"Foeldvari","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101979_bib45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9394(99)00034-3","article-title":"Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group","volume":"127","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2024.101979_bib47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.63.11.762","article-title":"Double-blind clinical trial of topical steroids in anterior uveitis","volume":"63","author":"Dunne","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaapos.2016.09.026","article-title":"Steroid-induced glaucoma in the pediatric population","volume":"21","author":"Nuyen","year":"2017","journal-title":"J AAPOS"},{"key":"10.1016\/j.berh.2024.101979_bib49","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajo.2011.10.008","article-title":"Efficacy and potential complications of difluprednate use for pediatric uveitis","volume":"153","author":"Slabaugh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib50","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/OPTH.S388982","article-title":"Ocular cyclopentolate: a mini review concerning its benefits and risks","volume":"16","author":"Contreras-Salinas","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib51","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/j.1755-3768.2010.02025.x","article-title":"Periocular corticosteroid injection in the management of uveitis in children","volume":"88","author":"Habot-Wilner","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-016-0265-9","article-title":"Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis","volume":"37","author":"Pichi","year":"2017","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijo.IJO_713_18","article-title":"Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis","volume":"67","author":"Jinagal","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40123-020-00328-9","article-title":"Bilateral 0.19 mg fluocinolone acetonide intravitreal implant in the successful treatment of juvenile idiopathic arthritis-associated uveitis and secondary macular oedema: a case report and review of intravitreal therapies","volume":"10","author":"Ansari","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.berh.2024.101979_bib55","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","article-title":"Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach","volume":"52","author":"Simonini","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101979_bib56","first-page":"1","article-title":"Methotrexate monotherapy in juvenile idiopathic arthritis associated uveitis: myth or reality?","author":"Tirelli","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib57","first-page":"1","article-title":"How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?","author":"Foeldvari","year":"2023","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.berh.2024.101979_bib58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","article-title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis","volume":"77","author":"Quartier","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101979_bib59","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2024.101979_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2019.06.007","article-title":"Adalimumab in juvenile idiopathic arthritis-associated uveitis: 5-year follow-up of the bristol participants of the SYCAMORE trial","volume":"207","author":"Horton","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib61","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14740338.2020.1763300","article-title":"Safety evaluations of adalimumab for childhood chronic rheumatic diseases","volume":"19","author":"Maccora","year":"2020","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.berh.2024.101979_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12969-023-00794-y","article-title":"Outcome of adalimumab monotherapy in paediatric non-infectious uveitis","volume":"21","author":"Al-Julandani","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2024.101979_bib63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10067-017-3890-4","article-title":"Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis","volume":"37","author":"Correll","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib64","first-page":"1043","article-title":"Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis","volume":"35","author":"Leinonen","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib65","article-title":"Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy","author":"Kreps","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.berh.2024.101979_bib66","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/keaa595","article-title":"Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis","volume":"60","author":"Maccora","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2024.101979_bib67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ajo.2022.06.024","article-title":"Alternative biologic therapy in children failing conventional TNF\u03b1 inhibitors for refractory, noninfectious, chronic anterior uveitis","volume":"244","author":"Miraldi Utz","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib68","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2024.101979_bib70","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2665-9913(20)30008-4","article-title":"Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial","volume":"2","author":"Ramanan","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib71","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.ophtha.2014.06.050","article-title":"Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema","volume":"121","author":"Mesquida","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2024.101979_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.851453","article-title":"Tocilizumab and Abatacept for the treatment of childhood chronic uveitis: a monocentric comparison experience","volume":"10","author":"Maccora","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.berh.2024.101979_bib73","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","article-title":"Anti-Interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients","volume":"69","author":"Calvo-R\u00edo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib74","first-page":"99","volume":"21","author":"Burlo","year":"2023"},{"key":"10.1016\/j.berh.2024.101979_bib75","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jcpt.12821","article-title":"Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: a report of two cases","volume":"44","author":"Dipasquale","year":"2019","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.berh.2024.101979_bib76","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3899\/jrheum.160231","article-title":"Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis","volume":"43","author":"Tappeiner","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acr.20359","article-title":"Abatacept for refractory juvenile idiopathic arthritis-associated uveitis: two new cases. Comment on the article by Zulian et al","volume":"63","author":"Elhai","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101979_bib78","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/acr.20115","article-title":"Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis","volume":"62","author":"Zulian","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2024.101979_bib79","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.140410","article-title":"Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis","volume":"42","author":"Tappeiner","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib80","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of Abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2011.07.001","article-title":"Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases","volume":"11","author":"Miserocchi","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2024.101979_bib82","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib83","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","article-title":"JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis","volume":"39","author":"Miserocchi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib84","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/09273948.2019.1605453","article-title":"Effect of Janus Kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis","volume":"27","author":"Bauermann","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib85","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/09273948.2022.2069128","article-title":"Beneficial effect of upadacitinib in an adult patient with juvenile idiopathic arthritis-associated uveitis after unsatisfactory response to tofacitinib: a case report","volume":"31","author":"Baquet-Walscheid","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2024.101979_bib86","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s13063-021-05651-5","volume":"22","author":"Ramanan","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.berh.2024.101979_bib87","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2024.101979_bib88","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2024.101979_bib89","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard-2022-222849","article-title":"Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial","volume":"82","author":"Brunner","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2024.101979_bib90","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14712598.2023.2215923","article-title":"Anti-IL17 treatment in childhood chronic rheumatic diseases","volume":"23","author":"Maniscalco","year":"2023","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.berh.2024.101979_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002693","article-title":"Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients","author":"Mart\u00edn-Varillas","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2024.101979_bib92","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/art.41888","article-title":"Optimizing the start time of biologics in polyarticular juvenile idiopathic arthritis: a comparative effectiveness study of childhood arthritis and rheumatology research alliance consensus treatment plans","volume":"73","author":"Kimura","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib93","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.41892","article-title":"Improved disease course associated with early initiation of biologics in polyarticular juvenile idiopathic arthritis: trajectory analysis of a childhood arthritis and rheumatology research alliance consensus treatment plans study","volume":"73","author":"Ong","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib94","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3899\/jrheum.161336","article-title":"Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis","volume":"44","author":"Simonini","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2024.101979_bib95","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s13063-020-04796-z","article-title":"Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial","volume":"21","author":"Acharya","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.berh.2024.101979_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2018.03.028","article-title":"Chronic anterior uveitis in children: psychosocial challenges for patients and their families","volume":"191","author":"Parker","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2024.101979_bib97","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12969-017-0189-6","article-title":"Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis","volume":"15","author":"Sen","year":"2017","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694224000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:34:04Z","timestamp":1727148844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694224000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1521694224000500"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2024.101979","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of JIA associated uveitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2024.101979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101979"}}